GO Term	Description	P-value	FDR q-value	Enrichment	N	B	n	b	Genes
GO:1900046	regulation of hemostasis	4.76E-7	3.24E-3	12.67	739	7	50	6	[PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, ABAT  -  4-aminobutyrate aminotransferase]
GO:0030193	regulation of blood coagulation	4.76E-7	1.62E-3	12.67	739	7	50	6	[PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, ABAT  -  4-aminobutyrate aminotransferase]
GO:0050818	regulation of coagulation	1.81E-6	4.1E-3	11.08	739	8	50	6	[PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, EPHB2  -  eph receptor b2, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, PRKCA  -  protein kinase c, alpha, ABAT  -  4-aminobutyrate aminotransferase]
GO:0021952	central nervous system projection neuron axonogenesis	8.87E-5	1.51E-1	11.82	739	5	50	4	[NFIB  -  nuclear factor i/b, NR4A2  -  nuclear receptor subfamily 4, group a, member 2, CDH11  -  cadherin 11, type 2, ob-cadherin (osteoblast), EPHB2  -  eph receptor b2]
GO:0021955	central nervous system neuron axonogenesis	2.53E-4	3.44E-1	9.85	739	6	50	4	[NFIB  -  nuclear factor i/b, NR4A2  -  nuclear receptor subfamily 4, group a, member 2, CDH11  -  cadherin 11, type 2, ob-cadherin (osteoblast), EPHB2  -  eph receptor b2]
GO:0061041	regulation of wound healing	3.38E-4	3.84E-1	5.54	739	16	50	6	[PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, ABAT  -  4-aminobutyrate aminotransferase]
GO:0006928	movement of cell or subcellular component	4.58E-4	4.46E-1	2.24	739	112	50	17	[DST  -  dystonin, DIXDC1  -  dix domain containing 1, TRIO  -  trio rho guanine nucleotide exchange factor, NEO1  -  neogenin 1, EPHB2  -  eph receptor b2, MYH10  -  myosin, heavy chain 10, non-muscle, DNER  -  delta/notch-like egf repeat containing, DOCK1  -  dedicator of cytokinesis 1, EXT1  -  exostosin glycosyltransferase 1, NFIB  -  nuclear factor i/b, ASTN2  -  astrotactin 2, NR4A2  -  nuclear receptor subfamily 4, group a, member 2, THBS1  -  thrombospondin 1, PRKCA  -  protein kinase c, alpha, GPC4  -  glypican 4, MYO1E  -  myosin ie, LAMB1  -  laminin, beta 1]
GO:1903034	regulation of response to wounding	4.96E-4	4.22E-1	5.22	739	17	50	6	[PLAUR  -  plasminogen activator, urokinase receptor, THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, EPHB2  -  eph receptor b2, PRKCA  -  protein kinase c, alpha, ABAT  -  4-aminobutyrate aminotransferase]
GO:0030198	extracellular matrix organization	9.9E-4	7.49E-1	5.68	739	13	50	5	[PXDN  -  peroxidasin homolog (drosophila), THBS1  -  thrombospondin 1, SERPINE1  -  serpin peptidase inhibitor, clade e (nexin, plasminogen activator inhibitor type 1), member 1, MYO1E  -  myosin ie, LAMB1  -  laminin, beta 1]
